Valeant Pharmaceuticals International Interest Expense:
155.32M for March 31, 2013Valeant Pharmaceuticals International Historical Interest Expense Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | 155.32M |
| Dec. 31, 2012 | 154.72M |
| Sept. 30, 2012 | 116.04M |
| June 30, 2012 | 100.61M |
| March 31, 2012 | 102.02M |
| Dec. 31, 2011 | 93.71M |
| Sept. 30, 2011 | 87.50M |
| June 30, 2011 | 83.07M |
| March 31, 2011 | 68.75M |
| Dec. 31, 2010 | 53.31M |
| Sept. 30, 2010 | 11.22M |
| June 30, 2010 | 9.952M |
| March 31, 2010 | 9.827M |
| Dec. 31, 2009 | 10.03M |
| Sept. 30, 2009 | 11.00M |
| June 30, 2009 | 4.049M |
| March 31, 2009 | 0.34M |
| Dec. 31, 2008 | 0.00 |
| Sept. 30, 2008 | 0.00 |
| June 30, 2008 | 0.00 |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
About Interest Expense
When companies borrow money to expand or maintain their business operations, they must pay interest on the money that they borrow. The interest expense is the annual accrued amount of interest that the company paid (or sometimes will have to pay) to its creditors.
A higher interest expense means that the company is paying more to its debtors. In general, a company's capital structure with a heavier debt focus will have higher interest expenses. Liquidity ratios such as EBIT/Interest Expense can help investors see if increasing Interest Expenses are problematic.
YCharts includes both operating interest expense and non-operating interest expense in our numbers.
Learn More
VRX Interest Expense Benchmarks
| Companies | |
|---|---|
| Actavis | 54.50M |
| Mylan | 77.99M |
| Warner Chilcott | 57.00M |
VRX Interest Expense Rankings
| Overall |
32nd percentile 5430 of 8005 |
| Sector |
6th percentile 640 of 686 in Healthcare |
| Industry |
5th percentile 64 of 68 in Drug Manufacturers - Specialty & Generic |
VRX Interest Expense Range, Past 5 Years
| Minimum | 0.00 | Jun 2008 |
| Maximum | 155.31M | Mar 2013 |
| Average | 53.57M |
